XELIRI regimen

{
  "id": "MLC-T-ONC-009401",
  "term": "XELIRI regimen",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI, CAPIRI regimen, and XELIRI.",
    "A chemotherapy regimen containing capecitabine and irinotecan used in the treatment of colorectal, esophageal and gastric cancer."
  ],
  "synonyms": [
    "CAPIRI",
    "CAPIRI regimen",
    "XELIRI",
    "capecitabine/irinotecan regimen",
    "capecitabine-irinotecan regimen",
    "Xeloda/Camptosar regimen",
    "Xeloda-Camptosar regimen",
    "Capiri"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/xeliri-regimen/"
}